• LAST PRICE
    6.5800
  • TODAY'S CHANGE (%)
    Trending Up0.0600 (0.9202%)
  • Bid / Lots
    6.5800/ 4
  • Ask / Lots
    6.5900/ 2
  • Open / Previous Close
    6.5400 / 6.5200
  • Day Range
    Low 6.4100
    High 6.6900
  • 52 Week Range
    Low 3.6700
    High 13.5000
  • Volume
    819,943
    above average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Wednesday's close: 6.52
TimeVolumeCOGT
09:32 ET65006.69
09:34 ET5006.64
09:36 ET4006.57
09:38 ET20006.56
09:39 ET66376.5424
09:41 ET25656.59
09:43 ET6016.62
09:45 ET9016.6
09:50 ET28466.58
09:52 ET9506.52
09:54 ET2006.56
09:56 ET4006.51
09:59 ET3006.5
10:01 ET16436.5376
10:03 ET5056.505
10:06 ET20006.495
10:08 ET41426.47
10:10 ET78686.42
10:12 ET29976.45
10:14 ET4526.4623
10:15 ET8356.47
10:17 ET37486.44
10:19 ET5006.43
10:21 ET10116.425
10:24 ET9886.45
10:26 ET15416.45
10:28 ET13006.48
10:30 ET4906.47
10:32 ET13146.47
10:33 ET3056.4788
10:35 ET19036.47
10:37 ET1006.48
10:39 ET25006.44
10:42 ET35686.45
10:44 ET66606.44
10:46 ET92926.44
10:48 ET41006.485
10:50 ET4006.495
10:53 ET16006.475
10:55 ET9446.49
10:57 ET7316.47
11:00 ET2006.47
11:02 ET17006.47
11:04 ET4006.47
11:06 ET13266.4888
11:08 ET6006.475
11:11 ET5007986.495
11:13 ET9016.53
11:15 ET1882266.52
11:18 ET48816.56
11:20 ET11006.57
11:22 ET15006.57
11:24 ET15606.585
11:27 ET25446.55
11:29 ET7016.56
11:31 ET13016.56
11:33 ET4026.58
Data delayed at least 15 minutes.
0 New Today
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesCOGT
Cogent Biosciences Inc
623.4M
-2.7x
---
United StatesOLMA
Olema Pharmaceuticals Inc
626.2M
-5.2x
---
United StatesNGNE
Neurogene Inc
633.1M
-1.8x
---
United StatesMLYS
Mineralys Therapeutics Inc
634.3M
-7.3x
---
United StatesCMPS
Compass Pathways PLC
610.2M
-3.6x
---
United StatesPHAT
Phathom Pharmaceuticals Inc
646.2M
-2.8x
---
As of 2024-03-28

Company Information

Cogent Biosciences, Inc. is a biotechnology company. The Company is focused on developing precision therapies for genetically defined diseases. The Company’s clinical program, bezuclastinib, is a selective tyrosine kinase inhibitor that is designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. KIT D816V is responsible for driving systemic mastocytosis, a serious disease caused by unchecked proliferation of mast cells. In addition to bezuclastinib, the Company is developing a portfolio of novel targeted therapies to help patients fighting serious, genetically driven diseases initially targeting mutations in FGFR2, ErbB2 and PI3Kα. SUMMIT is its randomized, global, multicenter, double-blind, placebo-controlled, multi-part Phase II clinical trial for patients with Non-AdvSM. APEX is an open-label, global, multicenter study evaluating the safety, efficacy, pharmacokinetic, and pharmacodynamic profiles of bezuclastinib.

Contact Information

Headquarters
275 Wyman Street, 3Rd FloorWALTHAM, MA, United States 02451
Phone
617-945-5576
Fax
---

Executives

Independent Chairman of the Board
Peter Harwin
President, Chief Executive Officer, Principal Executive Officer, Director
Andrew Robbins
Chief Financial Officer, Principal Accounting Officer, Principal Financial Officer
John Green
Chief Scientific Officer
John Robinson
Chief Medical Officer
Jessica Sachs

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$623.4M
Revenue (TTM)
$0.00
Shares Outstanding
95.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.51
EPS
$-2.40
Book Value
$2.99
P/E Ratio
-2.7x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.